Robot pancreas test adds second drug to control blood sugar spikes
NCT ID NCT06422325
Summary
This study tested whether adding a second drug called pramlintide to an automated insulin delivery system could better control blood sugar after meals in people with Type 1 diabetes. Thirty-three adults tried both the standard insulin-only system and the new insulin-plus-pramlintide system during separate clinic visits. The goal was to see if the two-drug approach kept blood sugar in a healthy range more effectively, especially after eating.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Oregon Health and Science University
Portland, Oregon, 97239, United States
Conditions
Explore the condition pages connected to this study.